I agree that this site is using cookies. You can find further informations here.
X
Koch, Annelize
34  results:
Search for persons X
?
1

A Phase 1 randomized study on the safety and pharmacokineti..:

Villoslada, Pablo ; Masso, Mar ; Paris, Stephane..
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

Safety, pharmacodynamics, and exposure-response modeling re..:

Hoppe, Bernd ; Koch, Annelize ; Cochat, Pierre...
Kidney International.  101 (2022)  3 - p. 626-634 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Safety, tolerability, pharmacokinetics and pharmacodynamics..:

Fedyk, Eric R. ; Zhao, Lin ; Koch, Annelize...
British Journal of Clinical Pharmacology.  86 (2020)  7 - p. 1314-1325 , 2020
Link: https://doi.org/10.1111/..
 
?
4

Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐53..:

Berger, Benjamin ; Kaufmann, Priska ; Koch, Annelize.
The Journal of Clinical Pharmacology.  60 (2020)  7 - p. 931-941 , 2020
Link: https://doi.org/10.1002/..
 
?
5

The Association for Human Pharmacology in the Pharmaceutica..:

Khan, Shahzadgai ; Albayaty, Muna ; Bush, James...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
6

The Association for Human Pharmacology in the Pharmaceutica..:

Reijntjes, Susan ; Albayaty, Muna ; Bush, James...
Frontiers in Pharmacology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
7

Evaluation of the safety profile of an electronic vapour pr..:

Walele, Tanvir ; Bush, Jim ; Koch, Annelize...
Regulatory Toxicology and Pharmacology.  92 (2018)  - p. 226-238 , 2018
Link: https://doi.org/10.1016/..
 
?
8

First-in-human studies of seletalisib, an orally bioavailab..:

Helmer, Eric ; Watling, Mark ; Jones, Emma...
European Journal of Clinical Pharmacology.  73 (2017)  5 - p. 581-591 , 2017
Link: https://doi.org/10.1007/..
 
?
9

GP2015, a proposed etanercept biosimilar: Pharmacokinetic s..:

von Richter, Oliver ; Skerjanec, Andrej ; Afonso, Miguel...
British Journal of Clinical Pharmacology.  83 (2016)  4 - p. 732-741 , 2016
Link: https://doi.org/10.1111/..
 
?
10

Neuroendocrine and sympathetic responses to an orexin recep..:

Patel, Ameera X. ; Miller, Sam R. ; Nathan, Pradeep J....
Psychopharmacology.  231 (2014)  19 - p. 3817-3828 , 2014
Link: https://doi.org/10.1007/..
 
?
11

Neural and Behavioral Effects of a Novel Mu Opioid Receptor..:

Cambridge, Victoria C. ; Ziauddeen, Hisham ; Nathan, Pradeep J....
Biological Psychiatry.  73 (2013)  9 - p. 887-894 , 2013
Link: https://doi.org/10.1016/..
 
?
12

Effects of genetic variation in the P2RX7 gene on pharmacod..:

McHugh, Simon M. ; Roman, Shilina ; Davis, Bill...
British Journal of Clinical Pharmacology.  74 (2012)  2 - p. 376-380 , 2012
Link: https://doi.org/10.1111/..
 
?
13

The relationship between fat mass, eating behaviour and obe..:

O'Neill, Barry V. ; Bullmore, Edward T. ; Miller, Sam...
Appetite.  59 (2012)  3 - p. 656-661 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Effects of mu opioid receptor antagonism on cognition in ob..:

Chamberlain, Samuel R. ; Mogg, Karin ; Bradley, Brendan P....
Psychopharmacology.  224 (2012)  4 - p. 501-509 , 2012
Link: https://doi.org/10.1007/..
 
?
15

Effect of the dopamine D3 receptor antagonist GSK598809 on ..:

Dodds, Chris M. ; O'Neill, Barry ; Beaver, John...
Appetite.  59 (2012)  1 - p. 27-33 , 2012
Link: https://doi.org/10.1016/..
 
1-15